Distribution and pharmacokinetics of etamicastat and its N-acetylated metabolite (BIA 5-961) in dog and monkey.

about

Distribution and pharmacokinetics of etamicastat and its N-acetylated metabolite (BIA 5-961) in dog and monkey.

Item

http://www.wikidata.org/entity/Q53544427

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Distribution and pharmacokinet ...... (BIA 5-961) in dog and monkey.

@en

Distribution and pharmacokinetics of etamicastat and its N-acetylated metabolite

@nl

type

Item

label

Distribution and pharmacokinet ...... (BIA 5-961) in dog and monkey.

@en

Distribution and pharmacokinetics of etamicastat and its N-acetylated metabolite

@nl

prefLabel

Distribution and pharmacokinet ...... (BIA 5-961) in dog and monkey.

@en

Distribution and pharmacokinetics of etamicastat and its N-acetylated metabolite

@nl

P1476

Distribution and pharmacokinet ...... (BIA 5-961) in dog and monkey.

@en

P2093

A I Loureiro

http://www.w3.org/2001/XMLSchema#string

P Soares-da-Silva

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, Tolerability, and Pharmacokinetics of Etamicastat, a Novel Dopamine-β-Hydroxylase Inhibitor, in a Rising Multiple-Dose Study in Young Healthy Subjects

Inter-species differences in drug properties.

Interspecies differences in pharmacokinetics and metabolism of S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethylphenyl)-propionamide: the role of N-acetyltransferase.

Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2

Update on the pharmacogenetics of NATs: structural considerations.

Nonlinear pharmacokinetics: clinical Implications.

Etamicastat, a new dopamine-ß-hydroxylase inhibitor, pharmacodynamics and metabolism in rat.

Enzymic N-acetylation of 2,4-toluenediamine by liver cytosols from various species.

Dose-dependent pharmacokinetics: experimental observations and theoretical considerations.

Human disposition, metabolism and excretion of etamicastat, a reversible, peripherally selective dopamine β-hydroxylase inhibitor.

P304

903-911

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/00498254.2015.1024780

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25869244

http://www.w3.org/2001/XMLSchema#string